What are Serotonin 5-HT3 receptor antagonist drugs?

Serotonin 5-HT3 receptor antagonist drugs are pharmacologic agents that share a common mechanism (typically targeting 5-HT3 receptor). 0 are currently marketed, with 4 more in clinical development.

Serotonin 5-HT3 receptor antagonist

0 marketed 3 in Phase 3 1 in Phase 2

This page covers all Serotonin 5-HT3 receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-HT3 receptor.

Targets

5-HT3 receptor

Phase 3 pipeline (3)

Standard: Ondansetron · CCTU · Oncology
Ondansetron works by blocking serotonin receptors in the body, which helps to reduce nausea and vomiting.
Ondansetron Oral Soluble Pellicles · The First Affiliated Hospital of Xinxiang Medical College · Oncology
Ondansetron works by blocking serotonin receptors in the body, which helps to reduce nausea and vomiting.
Ondansetron oral tablets · GlaxoSmithKline · Oncology
Ondansetron works by blocking serotonin receptors in the body, which helps to reduce nausea and vomiting.

Phase 2 pipeline (1)

BEKINDA · RedHill Biopharma Limited · Gastroenterology
Bekinda is a delayed-release tablet formulation of ondansetron, a serotonin 5-HT3 receptor antagonist.